Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
SPRB
SPRB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SPRB News
Spruce Biosciences Reports Disappointing FY EPS and Cash Position
1d ago
seekingalpha
Spruce Biosciences Advances TA-ERT for MPS IIIB Treatment
1d ago
Newsfilter
Spruce Biosciences Delays FDA Submission Timeline
Feb 18 2026
stocktwits
SPRUCE BIOSCIENCES STOCK JUMPS 8.16% AS COMPANY PREPARES FOR FDA FILING ON RARE PEDIATRIC BRAIN DISORDER TREATMENT
Feb 18 2026
moomoo
Spruce Biosciences Reports Positive FDA Meeting Outcomes for TA-ERT
Feb 18 2026
NASDAQ.COM
Spruce Biosciences Advances TA-ERT BLA Submission Following FDA Feedback
Feb 18 2026
Newsfilter
Harbour BioMed Exercises Warrant to Acquire 3.8% of Spruce Biosciences Inc.
Jan 21 2026
Benzinga
Harbour BioMed Acquires 3.8% Stake in Spruce Biosciences (SPRB)
Jan 19 2026
NASDAQ.COM
Harbour BioMed Acquires 3.8% Stake in Spruce Biosciences
Jan 19 2026
PRnewswire
Harbour BioMed Acquires 3.8% of Spruce Biosciences, Enhancing Strategic Partnership
Jan 19 2026
Newsfilter
Spruce Biosciences Secures $15 Million Loan to Support MPS IIIB Treatment Development
Jan 08 2026
Newsfilter
Cellectis SA Receives Buy Rating with $9 Price Target from Clear Street
Dec 23 2025
Benzinga
Spruce Biosciences Appoints Keli Walbert to Board, Aiming for TA-ERT Launch
Dec 15 2025
Newsfilter
Spruce Biosciences (SPRB) Price Target Raised by 55.76% to 213.69
Dec 06 2025
NASDAQ.COM
Post-Market Highlights: Jasper, NRx, Unicycive, Spruce, Evaxion, Solana, and Protara See Gains After Trading Hours
Dec 02 2025
NASDAQ.COM
Spruce Biosciences Shares Surge 2,900% Following FDA Breakthrough Therapy Designation Sparks Investor Excitement
Oct 09 2025
TipRanks
Show More News
